Cargando…

BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis

BACKGROUND: Breast cancer susceptibility gene (BRCA) mutation carriers are at an increased risk for breast, ovarian, prostate and pancreatic cancers. However, the role of BRCA is unclear in colorectal cancer; the results regarding the association between BRCA gene mutations and colorectal cancer ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Zhewen, Yang, Xiaobao, Tian, Mingwei, Zeng, Na, Bai, Zhigang, Deng, Wei, Zhao, Yanyan, Guo, Jianru, Yang, Yingchi, Zhang, Zhongtao, Yang, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464413/ https://www.ncbi.nlm.nih.gov/pubmed/37644384 http://dx.doi.org/10.1186/s12885-023-11328-w

Ejemplares similares

Sarcobesity, but not visceral fat, is an independent risk factor for complications after radical resection of colorectal cancer
por: Feng, Zhewen, et al.
Publicado: (2023)

Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer
por: Yang, Yingchi, et al.
Publicado: (2018)

Diagnostic Value of Inflammation-Related Indicators in Distinguishing Early Colon Cancer and Adenomatous Polyps
por: Feng, Zhewen, et al.
Publicado: (2023)

Ring finger protein 128 promotes, rather than inhibits, colorectal cancer progression by regulating the Hippo signaling pathway
por: Ning, Shili, et al.
Publicado: (2022)

Associations of Postoperative Complications Assessed by Clavien–Dindo Classification and Comprehensive Complication Index with Long-Term Overall Survival in Elderly Patients after Radical CRC Resection
por: Wang, Dong, et al.
Publicado: (2020)

Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort
por: Liu, Yun, et al.
Publicado: (2021)

Camrelizumab combined with apatinib and S-1 as second-line treatment for patients with advanced gastric or gastroesophageal junction adenocarcinoma: a phase 2, single-arm, prospective study
por: Jing, Chao, et al.
Publicado: (2022)

Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer
por: Wang, Dong, et al.
Publicado: (2019)

Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond BRCA1/BRCA2
por: Barbosa, Ana, et al.
Publicado: (2020)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
por: Evans, D. Gareth, et al.
Publicado: (2021)

Factors influencing traffic accident frequencies on urban roads: A spatial panel time-fixed effects error model
por: Wang, Wencheng, et al.
Publicado: (2019)

Performance evaluation of an amplicon‐based next‐generation sequencing panel for BRCA1 and BRCA2 variant detection
por: Park, Kuenyoul, et al.
Publicado: (2020)

Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients
por: Jones, T, et al.
Publicado: (2019)

NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases
por: Zanti, Maria, et al.
Publicado: (2020)

BRCA1 testing
por: Górski, Bohdan, et al.
Publicado: (2008)

Genetic testing for breast cancer risk, from BRCA1/2 to a seven gene panel: an ethical analysis
por: Gustavsson, Erik, et al.
Publicado: (2020)

Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome
por: Yoshihama, Tomoko, et al.
Publicado: (2020)

Usefulness of Inflammation-Based Prognostic Scores for Predicting the Risk of Complications After Radical Resection of Colorectal Carcinoma
por: Man, Wenhao, et al.
Publicado: (2020)

Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma
por: Takeuchi, Shoko, et al.
Publicado: (2018)

Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing
por: Zhang, Zeng-Yun-Ou, et al.
Publicado: (2021)

Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
por: Li, Hongyan, et al.
Publicado: (2019)

Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation–Negative Breast Cancer
por: Park, Ji Soo, et al.
Publicado: (2022)

The Efficacy of Platinum Chemotherapy in a Japanese Malignant Melanoma Patient With a BRCA2 Mutation Identified by Gene Panel Testing
por: Takayanagi-Hara, Reiko, et al.
Publicado: (2023)

BRCA Testing in Serbia and Montenegro
por: Brankovic-Magic, Mirjana
Publicado: (2006)

BRCA1 testing in Lithuania
por: Janavicius, Ramunas
Publicado: (2012)

Genetic testing for BRCA1 and BRCA2 mutations - ready for implementation?
por: Weber, BL
Publicado: (2000)

Current progress and future perspectives of neoadjuvant anti-PD-1/PD-L1 therapy for colorectal cancer
por: Yang, Zhengyang, et al.
Publicado: (2022)

Long-course chemoradiation plus concurrent/sequential PD-1 blockade as neoadjuvant treatment for MMR-status-unscreened locally advanced rectal cancer: protocol of a multicentre, phase 2, randomised controlled trial (the POLAR-STAR trial)
por: Pang, Kai, et al.
Publicado: (2023)

Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin
por: LIU, LIANCHENG, et al.
Publicado: (2016)

Validation of AmpliSeq NGS Panel for BRCA1 and BRCA2 Variant Detection in Canine Formalin-Fixed Paraffin-Embedded Mammary Tumors
por: Di Giacomo, Daniela, et al.
Publicado: (2022)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations
por: Birkbak, Nicolai Juul, et al.
Publicado: (2013)

Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing
por: Rohlin, Anna, et al.
Publicado: (2016)

Burden of colorectal cancer in China, 1990−2017: Findings from the Global Burden of Disease Study 2017
por: Yin, Jie, et al.
Publicado: (2019)

Identification of Recurrent Variants in BRCA1 and BRCA2 across Multiple Cancers in the Chinese Population
por: Jiang, Yue, et al.
Publicado: (2020)

RAD52 aptamer regulates DNA damage repair and STAT3 in BRCA1/BRCA2-deficient human acute myeloid leukemia
por: Xu, Yichuan, et al.
Publicado: (2020)

BRCA Testing Dichotomy in Saudi Arabia
por: Abusanad, Atlal
Publicado: (2019)

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
por: Chen-Shtoyerman, R, et al.
Publicado: (2001)

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes
por: Hodgson, Darren R., et al.
Publicado: (2018)

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
por: Osorio, A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nvoikf2g0qn6fr5n5g1gk7cr6n